NEW YORK, NY / ACCESS Newswire / March 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

NEW YORK, NY / ACCESS Newswire / March 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

Viatris Inc. closed 32.47% below its 52-week high of $13.55, which the company reached on November 25th.

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

One company that received approval for an insulin biosimilar in the US is Viatris, for its Semglee (insulin glargine-yfgn) product. In a recent fourth quarter investor call, Sanjeev Narula ...

You can now play an even larger range of puzzles on our site, every weekday and now also every Saturday. Check out our brand new puzzles below, from Hangman to Add Up and even a Jigsaw. Of course ...

After hours: March 21 at 7:49:24 PM EDT Loading Chart for VTRS ...

Financials are currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.